查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519468

2024-2032 年按生物標記類型、診斷技術、最終用戶和地區分類的腎臟生物標記市場報告

Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球腎臟生物標記市場規模達到13億美元。

腎臟生物標記是尿液分析中存在的細胞、蛋白質、脂質、microRNA、基因、代謝物或蛋白質體模式。它們有助於確定腎臟的腎小球濾過率 (GFR)，以分析其正常功能並評估致病過程或對治療介入的藥理反應。由於腎臟生物標記也有助於預測疾病進展和計算藥物劑量，因此它們在全球的醫院和診斷實驗室中得到了廣泛的應用。

腎臟生物標記市場趨勢：

慢性腎臟病（CKD）是一種發病率和死亡率較高的非傳染性疾病，已逐漸成為全球關注的公共衛生問題，其主要危險因子是糖尿病、高血壓和心臟病。慢性腎臟病患者數量的增加是推動市場成長的關鍵因素之一。此外，腎臟生物標記，包括血中尿素氮（BUN）、血清肌酸酐（SCr）、尿液白蛋白/蛋白和容量排泄，用於慢性腎臟病（CKD）的診斷和疾病監測。除此之外，產業投資者對世界各地人類腎臟疾病的新型單一生物標記和特定過程的生物標記組合越來越感興趣。這些新型生物標記提供重要的診斷和預後訊息，並有助於預測腎絲球病變、急性腎損傷 (AKI) 和常染色體顯性多囊性腎病變 (ADPKD) 的治療反應。除此之外，腎臟生物標記在各種規模的實驗室中變得易於使用和可行。這與基因組學、表觀遺傳學、轉錄組學、蛋白質組學和代謝組學的發展和整合一起，正在對市場產生積極影響。其他一些因素，例如蓬勃發展的醫療保健行業、不斷成長的老年人口以及全球 CKD 臨床試驗數量的增加，預計將促進市場的成長。

本報告回答的關鍵問題

  • 2023年全球腎臟生物標記市場規模有多大？
  • 2024-2032年全球腎臟生物標記市場的預期成長率是多少？
  • COVID-19 對全球腎臟生物標記市場有何影響？
  • 推動全球腎臟生物標記市場的關鍵因素是什麼？
  • 根據生物標記類型，全球腎臟生物標記市場的詳細情形如何？
  • 基於診斷技術的全球腎臟生物標記市場的詳細情形如何？
  • 基於最終用戶的全球腎臟生物標記市場的詳細情形如何？
  • 全球腎臟生物標記市場的關鍵區域有哪些？
  • 誰是全球腎臟生物標記市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腎臟生物標記市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場細分：依生物標記類型

  • 功能性生物標記
    • 市場走向
    • 關鍵環節
      • 血清肌酸酐
      • 血清胱抑素C
      • 尿液白蛋白
    • 市場預測
  • 上調蛋白質
    • 市場走向
    • 關鍵環節
      • 中性粒細胞明膠酶相關脂質運載蛋白 (NGAL)
      • 腎損傷分子1
      • 白細胞介素18
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：透過診斷技術

  • 酵素連結免疫吸附測定法 (ELISA)
    • 市場走向
    • 市場預測
  • 顆粒增強比濁免疫分析 (PETIA)
    • 市場走向
    • 市場預測
  • 比色測定
    • 市場走向
    • 市場預測
  • 化學發光免疫分析 (CLIA)
    • 市場走向
    • 市場預測
  • 液相層析質譜法 (LC-MS)
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診斷實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Beckman Coulter Inc. (Danaher Corporation)
    • bioMerieux SA
    • BioPorto A/S
    • Bio-Rad Laboratories Inc.
    • Enzo Biochem Inc.
    • F. Hoffmann-La Roche AG
    • PerkinElmer Inc.
    • Randox Laboratories Ltd.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5273

The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032.

Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends:

Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global renal biomarkers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on biomarker type, diagnostic technique and end user.

Breakup by Biomarker Type:

Functional Biomarker

Serum Creatinine

Serum Cystatin C

Urine Albumin

Up-regulated Protein

Neutrophil Gelatinase-Associated Lipocalin (NGAL)

Kidney Injury Molecule-1

INTERLEUKIN-18

Others

Breakup by Diagnostic Technique:

Enzyme-linked Immunosorbent Assay (ELISA)

Particle-enhanced Turbidimetric Immunoassay (PETIA)

Colorimetric Assay

Chemiluminescent Enzyme Immunoassay (CLIA)

Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End User:

Hospital

Diagnostic Laboratory

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global renal biomarkers market in 2023?
  • 2. What is the expected growth rate of the global renal biomarkers market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global renal biomarkers market?
  • 4. What are the key factors driving the global renal biomarkers market?
  • 5. What is the breakup of the global renal biomarkers market based on the biomarker type?
  • 6. What is the breakup of the global renal biomarkers market based on the diagnostic technique?
  • 7. What is the breakup of the global renal biomarkers market based on end user?
  • 8. What are the key regions in the global renal biomarkers market?
  • 9. Who are the key players/companies in the global renal biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Biomarker Type

  • 6.1 Functional Biomarker
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Serum Creatinine
      • 6.1.2.2 Serum Cystatin C
      • 6.1.2.3 Urine Albumin
    • 6.1.3 Market Forecast
  • 6.2 Up-regulated Protein
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
      • 6.2.2.2 Kidney Injury Molecule-1
      • 6.2.2.3 INTERLEUKIN-18
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Diagnostic Technique

  • 7.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colorimetric Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Chemiluminescent Immunoassay (CLIA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BioPorto A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 PerkinElmer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Randox Laboratories Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2023
  • Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2023
  • Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
  • Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
  • Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million US$), 2024-2032
  • Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million US$), 2024-2032
  • Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Renal Biomarkers Market: Competitive Structure
  • Table 7: Global: Renal Biomarkers Market: Key Players